William Chou's most recent trade in Passage Bio Inc was a trade of 58,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 58,000 | 58,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2026 | 10,000 | 10,600 (0%) | 0% | - | Common Stock | |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2026 | 10,000 | 10,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 18.44 per share. | 08 Jan 2026 | 4,076 | 6,524 (0%) | 0% | 18.4 | 75,159 | Common Stock |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 779,533 | 779,533 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 20,000 | 20,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | William Chou | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 575,000 | 575,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | William Chou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 608,615 | 608,615 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | William Chou | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 885,000 | 885,000 | - | - | Employee Stock Option (right to buy) |